News Release

Cost-effectiveness of a polypill for cardiovascular disease prevention in an underserved population

JAMA Cardiology

Peer-Reviewed Publication

JAMA Network

About The Study: The results of this economic evaluation suggest that cardiovascular polypill treatment (single pill containing a statin and 3 half-standard dose antihypertensives) could be a high value intervention for a low-income, majority Black population with limited access to health care services. It could additionally reduce health disparities.

Corresponding Author: To contact the corresponding author, Ciaran N. Kohli-Lynch, PhD, email ciaran.kohli-lynch@northwestern.edu.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamacardio.2024.4812)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.

#  #  #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamacardiology/fullarticle/10.1001/jamacardio.2024.4812?guestAccessKey=99044e91-31bb-43a6-bf32-d1e42e9b434c&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=010825


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.